Recent

% | $
Quotes you view appear here for quick access.

MannKind Corp. Message Board

  • itellthefuture777 itellthefuture777 Oct 10, 2009 2:38 PM Flag

    MEDTONE INHALER IS THE LAUNCH INHALER!

    If you listen to the last JMP you will clearly hear that the Medtone inhaler is the one that is in the NDA and that they are not putting the Dreamboat in it..because they do not want to disrupt the current NDA's approval track....
    The Dreamboat will come later...and that my friends is what I believe the wannabe partners are upset about..well..when Al launches with Medtone..realize that in an early talk the company said they were Pre-pared to go it alone..REMEMBER MINIMED!! WALLSTREET DARLING!!
    Walked away from those wannabes..and then made BILLIONS!!!!! And Mannkind is many magitudes larger then Minimed...If I was in charge at that wannabe partner...I would be shutting up my demanding attidude before I lost the partnership..well to late..NEXT partner?? SNY? 15Billion Euros and copromotion, and launch with Medtone..if you want!?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Will NOT LAUNCH with medtone inhaler. Mr. Mann stated during the Morgan Preso that MNKD will only launch with Dreamboat - and that FDA approval of the Dreamboat could be a major hurdle to overcome for a January launch date (2010) - IF THE FDA doesn't approve Dreamboat by the PDUFA date.

      As of the Morgan Preso, MNKD had submitted additional information to the FDA regarding the Dreamboat, but had not been given an indication as to whether or not the Dreamboat was going to be approved by the FDA nor was MNKD made aware as to the manner in which the approval would be granted.

      MNKD shareholders (and shorts alike) have two distinct issues to stay on top of:

      1. the FDA approval of Afresa and the technosphere delivery of the insulin. (1/16/2010 - PDUFA date)

      2. the FDA approval of the dreamboat inhaler - delivery method. (No approval date or approval track has been reported by the MNKD or the FDA)

      All, just my humble opinion.

    • you are to in love with al...this is a great product and delivery system...the cancer studies are to new,phase one...don't get crazy about that,not until you see great results in phase 2...and until afresa is approved without further testing this can implode...jmho

      • 1 Reply to hkleinkopfdpm
      • The reason I am excited about the cancer vaccine results is because..the Clinical trail website was updated on July 23 2009..and they went from saying just simply..Advanced Cancer to,
        http://clinicaltrials.gov/archive/NCT00423254/2009_07_23/changes

        Ovarian
        Melanoma
        Renal
        Prostate
        Colorectal
        Endometrial Carcinoma
        Cervical Carcinoma
        Testicular Cancer
        Thyroid Cancer
        Small Cell Lung Carcinoma
        Mesothelioma
        Breast Carcinoma
        Esophageal Carcinoma
        Gastric Cancer
        Pancreatic Carcinoma
        Neuroendocrine Cancer
        Liver Cancer
        Gallbladder Cancer
        Biliary Tract Cancer
        Anal Carcinoma
        Bone Sarcomas
        Soft Tissue Sarcomas
        Carcinoma of Unknown Origin, Primary
        Gallbladder Diseases
        Thoracic Neoplasms
        Liver Diseases
        Rectal Neoplasms
        Pancreatic Neoplasms
        Urogenital Neoplasms
        Rectal Diseases
        Neoplasms, Connective and Soft Tissue
        Endometrial Neoplasms
        Neoplasms by Site
        Lung Neoplasms
        Breast Diseases
        Endocrine Gland Neoplasms
        Digestive System Neoplasms
        Genital Neoplasms, Female
        Breast Neoplasms
        Endocrine System Diseases
        Testicular Neoplasms
        Genital Diseases, Male
        Carcinoma
        Carcinoma, Small Cell
        Neuroectodermal Tumors
        Neoplasms
        Lung Diseases
        Sarcoma
        Pancreatic Diseases
        Gastrointestinal Neoplasms
        Gallbladder Neoplasms
        Esophageal Diseases
        Anus Neoplasms

 
MNKD
0.8733-0.0945(-9.76%)Feb 8 4:00 PMEST